Access cutting-edge idiopathic pulmonary fibrosis treatment through this clinical trial at a research site in Kansas City. Study-provided care at no cost to qualified participants.
Access idiopathic pulmonary fibrosis specialists in Kansas City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related idiopathic pulmonary fibrosis treatment provided free
A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of MTX-463 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
Sponsor: Mediar Therapeutics
Check if you qualify for this idiopathic pulmonary fibrosis clinical trial in Kansas City, KS
If you're searching for idiopathic pulmonary fibrosis treatment options in Kansas City, KS, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Kansas City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced idiopathic pulmonary fibrosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.